The totally subcutaneous implantable-defibrillator (S-ICD) is a new alternative to the conventional transvenous ICD system to minimize intravascular lead complications. There are limited data describing the long-term performance of the S-ICD. This paper presents the first large international patient population collected as part of the EFFORTLESS S-ICD Registry.The EFFORTLESS S-ICD Registry is a non-randomized, standard of care, multicentre Registry designed to collect long-term, system-related, clinical, and patient reported outcome data from S-ICD implanted patients since June 2009. Follow-up data are systematically collected over 60-month post-implant including Quality of Life. The study population of 472 patients of which 241 (51%) were ...
Implantable cardioverter-defibrillators (ICDs) reduce mortality in both primary and secondary preven...
The recent introduction of subcutaneous implantable cardioverter defibrillator (S-ICD) has raised at...
International audienceAbstract BackgroundThe UNTOUCHED study will assess the safety and efficacy of ...
The totally subcutaneous implantable-defibrillator (S-ICD) is a new alternative to the conventional ...
Aims The totally subcutaneous implantable-defibrillator (S-ICD) is a new alternative to the conventi...
Aims The totally subcutaneous implantable-defibrillator (S-ICD) is a new alternative to the conventi...
BACKGROUND The entirely subcutaneous implantable cardioverter-defibrillator (S-ICD) is the first imp...
AbstractBackgroundThe entirely subcutaneous implantable cardioverter-defibrillator (S-ICD) is the fi...
The subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed to defibrillate ventri...
Objectives The purpose of the study was to evaluate the efficacy and safety of the entirely subcutan...
BACKGROUND The subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed to defibril...
Background: Leads in and on the heart of the transvenous implantable cardioverter defibrillator (ICD...
Objectives: The purpose of the study was to evaluate the efficacy and safety of the entirely subcuta...
This editorial refers to ‘Worldwide experiencewith a totally subcutaneous ICD: early results from th...
Implantable cardioverter-defibrillators (ICDs) reduce mortality in both primary and secondary preven...
The recent introduction of subcutaneous implantable cardioverter defibrillator (S-ICD) has raised at...
International audienceAbstract BackgroundThe UNTOUCHED study will assess the safety and efficacy of ...
The totally subcutaneous implantable-defibrillator (S-ICD) is a new alternative to the conventional ...
Aims The totally subcutaneous implantable-defibrillator (S-ICD) is a new alternative to the conventi...
Aims The totally subcutaneous implantable-defibrillator (S-ICD) is a new alternative to the conventi...
BACKGROUND The entirely subcutaneous implantable cardioverter-defibrillator (S-ICD) is the first imp...
AbstractBackgroundThe entirely subcutaneous implantable cardioverter-defibrillator (S-ICD) is the fi...
The subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed to defibrillate ventri...
Objectives The purpose of the study was to evaluate the efficacy and safety of the entirely subcutan...
BACKGROUND The subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed to defibril...
Background: Leads in and on the heart of the transvenous implantable cardioverter defibrillator (ICD...
Objectives: The purpose of the study was to evaluate the efficacy and safety of the entirely subcuta...
This editorial refers to ‘Worldwide experiencewith a totally subcutaneous ICD: early results from th...
Implantable cardioverter-defibrillators (ICDs) reduce mortality in both primary and secondary preven...
The recent introduction of subcutaneous implantable cardioverter defibrillator (S-ICD) has raised at...
International audienceAbstract BackgroundThe UNTOUCHED study will assess the safety and efficacy of ...